Literature DB >> 4341125

Inhibition of angiotensin conversion in experimental renovascular hypertension.

E D Miller, A I Samuels, E Haber, A C Barger.   

Abstract

Constriction of the renal artery and controlled reduction of renal perfusion pressure is followed by a prompt increase in systemic renin activity and a concomitant rise in blood pressure in trained, unanesthetized dogs. The elevated blood pressure induced by the renal artery stenosis can be prevented by prior treatment with the nonapeptide Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro, which blocks conversion of angiotensin I to angiotensin II. Further, the nonapeptide can restore systemic pressure to normnal in the early phase of renovascular hypertension. These results offer strong evidence that the renin-angiotensin system is responsible for the initiation of hypertension in the unilaterally nephrectomized dog with renal artery constriction.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4341125     DOI: 10.1126/science.177.4054.1108

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  9 in total

1.  Effect of angiotensin-converting enzyme inhibitor on response of plasma renin activity and aldosterone to tilting in man.

Authors:  J G Collier; J S Jenkins; J Keddie; M U Khan; B F Robinson
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

2.  Short-term saralasin blockade of renal hypertension in fetal lambs.

Authors:  D F Anderson; N D Binder
Journal:  J Physiol       Date:  1991-02       Impact factor: 5.182

3.  Reversal of renovascular hypertension by antibodies specific for angiotensin-converting enzyme.

Authors:  R A Markle; E H Sonnenblick; J M Conroy; R L Soffer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

4.  Angiotensin-converting enzyme from rabbit pulmonary particles.

Authors:  R L Soffer; R Reza; P R Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

5.  Inhibition of angiotensin-coverting enzyme by analogs of peptides from Bothrops jararaca venom.

Authors:  D W Cushman; J Pluscec; N J Williams; E R Weaver; E F Sabo; O Kocy; H S Cheung; M A Ondetti
Journal:  Experientia       Date:  1973-08-15

6.  Studies of plasma renin activity in coarctation of the aorta.

Authors:  C W Van Way; A M Michelakis; W J Anderson; A Manlove; J A Oates
Journal:  Ann Surg       Date:  1976-03       Impact factor: 12.969

7.  Influence of sodium balance on atrial natriuretic factor in rats with one-kidney, one-clip renal hypertension.

Authors:  A L Lattion; J P Flückiger; B Waeber; J Nussberger; J F Aubert; H R Brunner
Journal:  Experientia       Date:  1990-01-15

Review 8.  Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?

Authors:  M P Sambhi; H Gavras; J I Robertson; W M Smith
Journal:  West J Med       Date:  1993-03

9.  Interactions between coronary occlusion and the renin-angiotensin system in the dog.

Authors:  G Ertl; R W Alexander; R A Kloner
Journal:  Basic Res Cardiol       Date:  1983 Sep-Oct       Impact factor: 17.165

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.